JPH013192A - Furan compounds and oil and fat antioxidants containing them as active ingredients - Google Patents
Furan compounds and oil and fat antioxidants containing them as active ingredientsInfo
- Publication number
- JPH013192A JPH013192A JP62-155311A JP15531187A JPH013192A JP H013192 A JPH013192 A JP H013192A JP 15531187 A JP15531187 A JP 15531187A JP H013192 A JPH013192 A JP H013192A
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- formulas
- hydrogen atom
- tables
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003963 antioxidant agent Substances 0.000 title claims description 5
- 239000004480 active ingredient Substances 0.000 title claims description 3
- 150000002240 furans Chemical class 0.000 title 1
- 230000003078 antioxidant effect Effects 0.000 claims description 14
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 5
- -1 furan compound Chemical class 0.000 claims description 5
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 description 18
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 235000020778 linoleic acid Nutrition 0.000 description 9
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 235000019198 oils Nutrition 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 229940087168 alpha tocopherol Drugs 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 239000002502 liposome Substances 0.000 description 6
- 229960000984 tocofersolan Drugs 0.000 description 6
- 239000002076 α-tocopherol Substances 0.000 description 6
- 235000004835 α-tocopherol Nutrition 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 239000000693 micelle Substances 0.000 description 5
- 235000014593 oils and fats Nutrition 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 235000019485 Safflower oil Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 235000005713 safflower oil Nutrition 0.000 description 4
- 239000003813 safflower oil Substances 0.000 description 4
- 229930003799 tocopherol Natural products 0.000 description 4
- 239000011732 tocopherol Substances 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 108010058864 Phospholipases A2 Proteins 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 238000006701 autoxidation reaction Methods 0.000 description 3
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000019688 fish Nutrition 0.000 description 3
- 238000004817 gas chromatography Methods 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 239000008348 synthetic phosphatidyl choline Substances 0.000 description 3
- 235000010384 tocopherol Nutrition 0.000 description 3
- 229960001295 tocopherol Drugs 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000011481 absorbance measurement Methods 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 229940083466 soybean lecithin Drugs 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 239000001149 (9Z,12Z)-octadeca-9,12-dienoate Substances 0.000 description 1
- WTTJVINHCBCLGX-UHFFFAOYSA-N (9trans,12cis)-methyl linoleate Natural products CCCCCC=CCC=CCCCCCCCC(=O)OC WTTJVINHCBCLGX-UHFFFAOYSA-N 0.000 description 1
- ZZBGQTCQWGAOGS-UHFFFAOYSA-N 2,2-dimethylpropyl-[2,2-dimethylpropyl(dimethyl)silyl]oxy-dimethylsilane Chemical compound CC(C)(C)C[Si](C)(C)O[Si](C)(C)CC(C)(C)C ZZBGQTCQWGAOGS-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical class OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- LNJCGNRKWOHFFV-UHFFFAOYSA-N 3-(2-hydroxyethylsulfanyl)propanenitrile Chemical compound OCCSCCC#N LNJCGNRKWOHFFV-UHFFFAOYSA-N 0.000 description 1
- GGNZKBPHAMNUOU-UHFFFAOYSA-N 9-(3,4-dimethyl-5-pentylfuran-2-yl)-nonanoic acid Chemical compound CCCCCC=1OC(CCCCCCCCC(O)=O)=C(C)C=1C GGNZKBPHAMNUOU-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 239000008777 Glycerylphosphorylcholine Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 102100037611 Lysophospholipase Human genes 0.000 description 1
- PKIXXJPMNDDDOS-UHFFFAOYSA-N Methyl linoleate Natural products CCCCC=CCCC=CCCCCCCCC(=O)OC PKIXXJPMNDDDOS-UHFFFAOYSA-N 0.000 description 1
- 102000014384 Type C Phospholipases Human genes 0.000 description 1
- 108010079194 Type C Phospholipases Proteins 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000005639 glycero group Chemical group 0.000 description 1
- 229960004956 glycerylphosphorylcholine Drugs 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- ZZSFTHVENQKCDJ-UHFFFAOYSA-N methyl 8-(5-hexylfuran-2-yl)octanoate Chemical compound CCCCCCC1=CC=C(CCCCCCCC(=O)OC)O1 ZZSFTHVENQKCDJ-UHFFFAOYSA-N 0.000 description 1
- 125000001402 nonanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000002530 phenolic antioxidant Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- LFGREXWGYUGZLY-UHFFFAOYSA-N phosphoryl Chemical group [P]=O LFGREXWGYUGZLY-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical group CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、油脂酸化防止作用を有するフラン化合物に関
し、更にまたその様な化合物を有効成分とする油脂の酸
化防止剤に関するものであり、人或いは動物に使用され
る食品、化粧品或いは医薬品添加物等の油脂の酸化が開
運と成る分野に利用される。Detailed Description of the Invention [Field of Industrial Application] The present invention relates to a furan compound having an antioxidant effect on fats and oils, and furthermore to an antioxidant for fats and oils containing such a compound as an active ingredient. Alternatively, it can be used in fields where oxidation of oils and fats, such as foods used for animals, cosmetics, or pharmaceutical additives, is beneficial.
[従来の技術及びその問題点]
従来、人或いは動物に摂取される天然油脂の酸化防止に
はBHT或いはBHA等の合成化合物及び天然のトコフ
ェロール(dl−トコフェロールを含む)等が使われて
きたが、近時、より自然に近いものの使用を、との観点
から後者が重要視されつつある。又、助剤効果を期待し
てクエン酸、アスコルビン酸などを共存させ有効な場合
も有るが、酸性物質であること(溶解性の問題)、水性
で使用されるアスコルビン酸は金属イオンの混在の下で
プロオキシダントとして酸化を促進すること等の問題点
が有り、必ずしも全てを充たすものではなかった
[問題点を解決するための手段]
本発明者等は、油脂類の酸化防止に就いて長年にわたり
鋭意研究を進めていたところ、一般式
及び一般式
CH−〇A
を有する化合物が、優れた油脂酸化防止作用を有するこ
とを見出して本発明を完成した。[Prior art and its problems] Conventionally, synthetic compounds such as BHT or BHA and natural tocopherols (including dl-tocopherol) have been used to prevent the oxidation of natural oils and fats ingested by humans or animals. Recently, the latter has been gaining importance from the perspective of using materials that are closer to nature. In addition, it is sometimes effective to coexist with citric acid, ascorbic acid, etc. in the hope of having an auxiliary effect, but it is an acidic substance (solubility problem), and ascorbic acid used in aqueous form may be contaminated with metal ions. [Means for solving the problem] The present inventors have long experience in preventing oxidation of oils and fats. As a result of extensive research, it was discovered that compounds having the general formula and the general formula CH-○A have excellent oil and fat oxidation inhibitory effects, and the present invention was completed.
上記一般式(I)及び(II)において、R□は水素原
子、炭素数1〜24の直鎖状又は分岐鎖状のアルキル基
、同アルケニル基、グリコリル基、又はコレステリール
基を示し、R2は炭素数1〜24の直鎖状又は分岐鎖状
のアルキル基、同アルケニル基、グリコリル基、コレス
テリール基又は基
を示し、Aは水素原子、−p(=o) (OH)2、−
P (=0) (OH) −0−(CH2)z −B
又は基を示し、X及びYは同一か異なって水素原子又は
メチル基を示し、Bは−Nl(2又は−N(CH,)3
を示す。m及びnは2〜14の整数を示す。In the above general formulas (I) and (II), R□ represents a hydrogen atom, a linear or branched alkyl group having 1 to 24 carbon atoms, an alkenyl group, a glycolyl group, or a cholesteryl group, and R2 represents a linear or branched alkyl group, alkenyl group, glycolyl group, cholesteryl group or group having 1 to 24 carbon atoms, A is a hydrogen atom, -p(=o) (OH)2, -
P (=0) (OH) -0-(CH2)z -B
or a group, X and Y are the same or different and represent a hydrogen atom or a methyl group, and B is -Nl(2 or -N(CH,)3
shows. m and n represent integers of 2 to 14.
式(I)及び式(II)を有する化合物の一部は天然に
存在することが知られた化合物である[RoL、クラス
等、リビット9巻1004頁(1974) ; 同誌1
0巻695頁(1975) ; 同誌17巻828頁(
1977);渡辺等、ケミカルアント ファーマシュー
チ力ルブレチン32巻328】頁(1984)等〕が、
生物学的に、又工学的にその作用は知られていない。Some of the compounds having formula (I) and formula (II) are compounds known to exist naturally [RoL, Klass et al., Rivit 9, p. 1004 (1974);
Vol. 0, p. 695 (1975); Vol. 17, p. 828 (
(1977); Watanabe et al. (1984) et al.
Its action is unknown biologically or technologically.
本発明者等は、前記式(I)及び(II)を有する化合
物を合成し、種々の状態における油脂の酸化防止作用を
検討し、その有効性を発見した。The present inventors synthesized compounds having the above formulas (I) and (II), studied their antioxidant effects on fats and oils under various conditions, and discovered their effectiveness.
本発明に係る化合物群は、前記のようにフランを有する
脂肪酸(以下、FAと略する)である。FAは前記文献
にも明らかなごとく、淡水魚中に広く分布し、更に鱈、
鮭等の海産魚類にもコレステロールエステル、トリグリ
セリドとして少量ながら含まれており、これらの魚類及
びその油(鱈肝油等)は永年にわたって賞味されてきて
おり、安全性、味、香り等の点で問題は無い。As described above, the compound group according to the present invention is a fatty acid containing furan (hereinafter abbreviated as FA). As is clear from the above literature, FA is widely distributed in freshwater fish, and is also found in cod, cod, etc.
Cholesterol esters and triglycerides are also contained in small amounts in marine fish such as salmon, and these fish and their oils (cod liver oil, etc.) have been enjoyed for many years, but there are problems in terms of safety, taste, aroma, etc. There is no.
FAは天然の脂肪酸と炭素鎖長がほぼ同じであり、カル
ボン酸を同じ位置に持つことにより水の存否にかかわら
すあらゆる状態で油脂との親和性が極めて良い。更にフ
ラン環の位置が不飽和脂肪酸の二重結合の占める位置と
ほぼ同様のところであり、酸化反応に際し相互作用を起
こすに好都合である。こうして化合物(II)は乳化状
態、ミセル又はリポソーム中に積極的に混和し顕著な抗
酸化作用を示すのみならす、一般に使われるトコフェロ
ール等の抗酸化剤の作用を著しく助長する。FAはジフ
ェニルビクリルヒドラジル(DPPH)とは反応しない
こと、リノール酸ハイドロパー万モサイドに加えるとP
Ovを減少することから、この酸はラジカル連鎖反応を
停止だせて作用するのではなく、ハイドロパーオキサイ
ドを分解して抗酸化作用を示すものである。FA has almost the same carbon chain length as natural fatty acids, and by having carboxylic acid in the same position, it has extremely good affinity with fats and oils in all conditions, regardless of the presence or absence of water. Furthermore, the position of the furan ring is almost the same as the position occupied by the double bond of the unsaturated fatty acid, which is convenient for interaction during the oxidation reaction. In this way, compound (II) is actively mixed into emulsified state, micelles or liposomes, and not only exhibits a remarkable antioxidant effect, but also significantly enhances the action of commonly used antioxidants such as tocopherol. FA does not react with diphenylvicrylhydrazyl (DPPH), and when added to linoleic acid hydropermicide, P
Since this acid reduces Ov, it does not act by stopping the radical chain reaction, but decomposes hydroperoxide and exhibits an antioxidant effect.
前記一般式(I)のエステル類は遊離の酸から常法によ
って合成される。また遊離の酸は公知の方法に従って合
成されるC M、S、F。The esters of the general formula (I) are synthesized from free acids by conventional methods. In addition, free acids are CM, S, and F synthesized according to known methods.
リーケンジー等、ケミカストリーアンドフイジックスオ
ブ リピッド、20巻 1頁(1978) ; C,H
,ラーン等、ジャーナルオフオルガニック ケミストリ
ー44巻3420頁(1979) ; R。Leekenzie et al., Chemistry and Physics of Lipids, Vol. 20, p. 1 (1978); C, H
, Rahn et al., Journal of Organic Chemistry, Vol. 44, p. 3420 (1979); R.
ショーデル等、ヘルベチカ キミ力アクタ68巻162
4頁(1985))。Schodel et al., Helvetica Kimi Power Acta Volume 68, 162
4 (1985)).
前記一般式(1,I )を有する化合物の一部は、A置
換クリセロールに必要とするFA2分子を脱水縮合させ
ることによって1.2位FA置換グリセロA化合物を合
成することができる。また、他の化合物は同様にして得
られる5n−II化合物を原料として、ホスホリパーゼ
A2の酵素反応によりリゾ体とし、遊離の一0f−1と
なった2位に求める脂肪酸を再度脱水縮合させることに
よって得られる。For some of the compounds having the general formula (1,I), a glycero A compound substituted with FA at the 1.2-position can be synthesized by dehydrating and condensing two molecules of FA required for A-substituted chrycerol. In addition, other compounds are obtained by using the 5n-II compound obtained in the same manner as a raw material, converting it into a lyso form by the enzymatic reaction of phospholipase A2, and dehydrating and condensing the desired fatty acid at the 2-position, which has become free 10f-1, again. can get.
[実施例]
次に実施例を挙げて本発明を更に具体的に説明するが、
本発明はこれによって限定されるものではない。[Example] Next, the present invention will be explained in more detail with reference to Examples.
The present invention is not limited thereby.
実施例1 ジー9−(3、4−ジメチル−5−ペンチル
−2−フリル)ノナノイルホスファチジルコリンの合成
L−d−グリセロホスホリルコリン・塩化カドミウム塩
3.4mmolを150耐の無水クロロボルムに溶かし
、8.5mmolの9−(3,4−ジメチル−5−ペン
チル−2−フリル)ノナン酸と10mmolのジメチル
アミノピリジン及び27mmolのDCCを加え、18
時間放置して反応を完結した。シリカゲルカラムクロマ
トグラフィーで精製したものはTLCで単一であり、無
水塩酸メタノールでメタツリシスして得られたフラン脂
肪酸メチルエステルのガスクロマトグラフィーによる定
量値はリン酸1に対してほぼ2であった。Example 1 Synthesis of di-9-(3,4-dimethyl-5-pentyl-2-furyl)nonanoylphosphatidylcholine 3.4 mmol of L-d-glycerophosphorylcholine cadmium chloride salt was dissolved in 150-proof anhydrous chloroborum, and 8. 5 mmol of 9-(3,4-dimethyl-5-pentyl-2-furyl)nonanoic acid, 10 mmol of dimethylaminopyridine and 27 mmol of DCC were added, and 18
The reaction was completed after being left for some time. The product purified by silica gel column chromatography was found to be single by TLC, and the quantitative value of furan fatty acid methyl ester obtained by metalysis with anhydrous hydrochloric acid and methanol by gas chromatography was approximately 2 to 1 of phosphoric acid.
実施例2 9−(3,4−ジメチル−5−ベンチルー2
−フリル)ノナノイル−9,12−オクタデカジニノイ
ルーホスファチジルコリンの合成
実施例1で得られた化合物0.012mmolを5ml
のエーテル−エタノール(19:1)に溶がし、O,1
mlのホスホリパーゼA2酵素液(1mg酵素450単
位/1ml 0.2mol トリス塩酸、 pH7,
5)と、0.05m1の0.2mol塩化カドミウムを
加え、5秒間ソニックし、37℃で16時間反応させる
。水層を取りエーテルで洗った後、水をとばしエタノー
ルを加えて移行させ、遠心分離によって沈殿物を除去し
た後、エタノールを留去し、エーテルで洗浄した後、再
度エタノールに溶がしエーテルを加えて沈殿物を集める
。Example 2 9-(3,4-dimethyl-5-benzene 2
Synthesis of 0.012 mmol of the compound obtained in Example 1 of -furyl)nonanoyl-9,12-octadecadininoyl-phosphatidylcholine in 5 ml
Dissolved in ether-ethanol (19:1), O,1
ml of phospholipase A2 enzyme solution (1 mg enzyme 450 units/1 ml 0.2 mol Tris-HCl, pH 7,
5) and 0.05 ml of 0.2 mol cadmium chloride are added, sonicated for 5 seconds, and reacted at 37°C for 16 hours. After taking the aqueous layer and washing it with ether, the water was blown off and ethanol was added to transfer it. After removing the precipitate by centrifugation, the ethanol was distilled off and washed with ether, then dissolved in ethanol again to remove the ether. Additionally, collect the precipitate.
得られた化合物はグリセリル基の2位が遊離となったリ
ゾ体である。これを5mlの無水クロロホルム中0.0
2mmolのリノール酸と0.02mmolのジメチル
アミノピリジンと0.06mmolのDCCにより2位
のアシル化を行なった。シリカゲルカラムクロマトグラ
フィーで精製する。このものはTLCで単一スポットを
示し、ホスホリパーゼA2酵素処理によりほぼ1mo1
当量のリノール酸を遊離する。メタツリシスして得られ
たFAとリノール酸の各エステルの量比はほぼl:1で
あり所期の化合物であることを示す。The obtained compound is a lyso compound in which the 2-position of the glyceryl group is free. This was added in 5 ml of anhydrous chloroform with 0.0
Acylation at the 2-position was performed using 2 mmol of linoleic acid, 0.02 mmol of dimethylaminopyridine, and 0.06 mmol of DCC. Purify by silica gel column chromatography. This showed a single spot on TLC and was treated with approximately 1 mol of phospholipase A2 enzyme.
An equivalent amount of linoleic acid is liberated. The quantitative ratio of FA and each ester of linoleic acid obtained by metatolysis was approximately 1:1, indicating that the compound was the desired compound.
実施例3 マススペクトル
実施例1の方法に従ってジー8−(5−へキシル−2−
フリル)オクタノイル−ホスファチジルコリンをどうせ
いした後、ホスホリパーゼCを作用させてグリセリル基
の3位を遊離とした後、t−ブチルジメチルシリルクロ
リドを反応させてt−ブチルトリメチルシリルエーテル
としてマススペクトルを測定し7’−(70+++eV
)。Example 3 Mass spectra Di-8-(5-hexyl-2-
(Furyl) After treating octanoyl-phosphatidylcholine, phospholipase C was applied to liberate the 3-position of the glyceryl group, and t-butyldimethylsilyl chloride was reacted to form t-butyltrimethylsilyl ether. Mass spectra were measured.7' −(70+++eV
).
M/e: 701(N−57)、351(acyl+7
4)、281,277(acyl)、207,165(
フラン環、base peak)、731.2−ジ−バ
ルミトイル−グリセロ−3−t−ブチルトリメチルシリ
ルエーテルのマススペクトルM/ e : 625(
M−57)、313(acyl+74)、239(ac
yl)/
11一
実施例4 リノール酸メチル油に対する抗酸化作用
1gのリノール酸メチルエステルに0.01gのメチル
8−(5−へ≦シルー2−フリル)7rクタノエート(
FAとする)を加えた時の抗酸化作用を同量のα−トコ
フェロール(TOとする)と比較した場合、 POV、
COV (45℃恒温器中遮光状態)値共、初期値は
好結果を示した。M/e: 701 (N-57), 351 (acyl+7
4), 281,277 (acyl), 207,165 (
Furan ring, base peak), 731. Mass spectrum of 2-di-balmitoyl-glycero-3-t-butyltrimethylsilyl ether M/e: 625 (
M-57), 313 (acyl+74), 239 (ac
yl)/11-Example 4 Antioxidant effect on methyl linoleate oil 0.01 g of methyl 8-(5-to≦sil-2-furyl)7r ctanoate (
When comparing the antioxidant effect when adding FA) with the same amount of α-tocopherol (TO), POV,
The initial COV (45° C. incubator, shielded from light) values showed good results.
実施例5 サフラワー油に対する抗酸化作用サフラワー
油に対するメチル8−(5−へキシル−2−フリル)オ
クタノエート(FA)の作用を見た結果は以下の通りで
ありその有効性が判る。Example 5 Antioxidant effect on safflower oil The effects of methyl 8-(5-hexyl-2-furyl) octanoate (FA) on safflower oil are as follows, demonstrating its effectiveness.
サフラワー油は、HPLCによりODCカラム蛍光測定
により0.026%のα−トコフェロールを含有してい
たので、その増強効果を見たものである。Safflower oil contained 0.026% α-tocopherol as determined by HPLC and ODC column fluorescence measurement, so the enhancement effect was investigated.
サフフラワー油2g、試料0.02gを添加。Add 2g of safflower oil and 0.02g of sample.
45°C1恒温器、遮光。45°C1 incubator, shielded from light.
実施例6 リノール酸の水性ミセル状態における抗酸化
作用
リノール酸の水性ミセル状態に対するg−(3゜4−ジ
メチル−5−ベンチルー2−フリル)ノナン酸(FA)
、の抗酸化作用について、ラジカル反応で生成する共役
ジエンを234nmの0.0.で測定すると共に、リノ
ール酸の残存量をガスクロマトグラフィーで測定した。Example 6 Antioxidant effect of linoleic acid in aqueous micelle state g-(3゜4-dimethyl-5-benzene-2-furyl)nonanoic acid (FA) on linoleic acid in aqueous micelle state
Regarding the antioxidant effect of conjugated diene generated by radical reaction, 234 nm 0.0. At the same time, the remaining amount of linoleic acid was measured by gas chromatography.
α−トコフェロールとの共同作用は特に有力であった。The synergy with α-tocopherol was particularly potent.
100m1のリン酸緩衝液pH6,9に70mgのリノ
ール酸、 0.5gのTνeen 20を加えミセル状
態にし、各試薬を加えて24〜26°Cで反応を行なっ
た。残存リノール酸量はエーテル抽出後トリメチルシリ
ルジアゾメタンでメチル化し、ガスクロマトグラフィー
で定量した。70 mg of linoleic acid and 0.5 g of Tνeen 20 were added to 100 ml of phosphate buffer pH 6.9 to form micelles, each reagent was added, and a reaction was carried out at 24 to 26°C. The amount of residual linoleic acid was methylated with trimethylsilyldiazomethane after extraction with ether, and quantified by gas chromatography.
234nmの0.D、の経時変化と残存リノール酸実施
例7 合成ホスファチジルコリン リポソームに対する
FA誘導体の抗酸化作用−一一一吸光度測定
実施例2におけると同様にして合成されたステアロイル
ーリルイルーホスファチジルコリン30μmolをクロ
ロホルムに溶がし、1mo1%の試料と、ラジカル開始
剤として7.5μmolの2,2′−アゾビス−(2,
4−ジメチルニトリル) (AMI/N)を加え、常温
で溶媒を減圧留去しフラスコ器壁にフィルム状にコート
した後、3m]の0.1N NaC1溶液を加えて振と
うしリポソームとした後、50°Cに温めて攪拌しなが
ら反応を行なった。経時的に50μmの反応液を取り4
mlのエタノールを加え233nmの吸光度を測定し
た。234nm 0. D. Changes over time and residual linoleic acid Example 7 Synthetic phosphatidylcholine Antioxidant effect of FA derivatives on liposomes - 111 Absorbance measurement 30 μmol of stearoylyl phosphatidylcholine synthesized in the same manner as in Example 2 was dissolved in chloroform. 1mol1% of the sample and 7.5μmol of 2,2'-azobis-(2,
After adding 4-dimethylnitrile (AMI/N) and evaporating the solvent under reduced pressure at room temperature to coat the flask wall in a film form, add 3 m] of 0.1N NaCl solution and shake to form liposomes. The reaction was carried out while warming to 50°C and stirring. Take 50 μm of reaction solution over time 4
ml of ethanol was added and the absorbance at 233 nm was measured.
F3: 9−(3,4−ジメチル−5−ベンチルー2−
フリル)ノナノイル
18:2 :リルオイル
P:ホスホリル
C:コリン
実施例8 大豆レシチンリポソームの自動酸化に対する
FA誘導体(式(II)化合物)の抗酸化作用−−−一
吸光度測定
実施例7と全く同様に行なった。大豆レシチンの平均分
子量は775とした。F3: 9-(3,4-dimethyl-5-benzene-2-
Furyl) nonanoyl 18:2 : Riluoyl P: Phosphoryl C: Choline Example 8 Antioxidant effect of FA derivative (formula (II) compound) on autoxidation of soybean lecithin liposome --- Absorbance measurement exactly the same as Example 7 I did it. The average molecular weight of soybean lecithin was 775.
実施例9 合成ホスファチジルコリン リポソームの自
動酸化に対するフランカルボン酸(FA)とトコフェロ
ール(TO)の効果実施例7と全く同様に反応を行なっ
た。Example 9 Effect of furocarboxylic acid (FA) and tocopherol (TO) on autoxidation of synthetic phosphatidylcholine liposomes The reaction was carried out in exactly the same manner as in Example 7.
実施例10 合成ホスファチジルコリンリポソームの
自動酸化における酸素吸収に対するFAの効果
実施例7と同じ反応条件で反応を行なったが、反応温度
は37℃を維持させた、溶存酸素量はYSI mode
l 53酸素モニターにより測定を行なった。残存酸素
量(%)で示す。Example 10 Effect of FA on oxygen absorption during autoxidation of synthetic phosphatidylcholine liposomes The reaction was carried out under the same reaction conditions as in Example 7, except that the reaction temperature was maintained at 37°C, and the amount of dissolved oxygen was adjusted to YSI mode.
Measurements were made with a 153 oxygen monitor. Shown as residual oxygen amount (%).
FA、TOは実施例9におけるものと同意義を示す。FA and TO have the same meanings as in Example 9.
[発明の効果]
フランカルボン酸化合物はエステル型として油脂そのも
のに直接添加して酸化防止作用が見られる。一般に天然
油脂はトコフェロール等のフェノール性抗酸化剤を含む
か或いは意図的に添加しており、この様な状態にフラン
カルボン酸化合物を加えた場合、より効果が増強ごおる
。一方、水と共存する状態の乳化状油脂、即ち水性ミセ
ル或いはリポソーム状の油脂の場合、極性グループを有
する型で安定性を保っているが、フランカルボン酸化合
物を酸化防止剤として使用するには遊離の酸として、更
により好ましくはリポソーム状にたいしては一般式(I
I)で示されるようなグリセライドの型として積極的に
混和させることにより、有効性をより効果あらしめるこ
とができる。[Effects of the Invention] When the furancarboxylic acid compound is added in the form of an ester directly to fats and oils itself, an antioxidant effect is observed. Generally, natural oils and fats contain or intentionally add phenolic antioxidants such as tocopherol, and when a furancarboxylic acid compound is added to such a state, the effect is further enhanced. On the other hand, in the case of emulsified oils and fats that coexist with water, that is, aqueous micelles or liposomal oils, they maintain stability as they have polar groups, but it is difficult to use furancarboxylic acid compounds as antioxidants. As the free acid, even more preferably in liposomal form the general formula (I
By actively incorporating the glyceride type shown in I), the effectiveness can be further enhanced.
Claims (1)
のアルキル基、同アルケニル基、グリコリル基、コレス
テリール基又は基▲数式、化学式、表等があります▼ を示し、A′は−P(=O)(OH)_2、−P(=O
)(OH)−O−(CH_2)_2−Bを示し、X及び
Yは同一か異なって水素原子又はメチル基を示し、Bは
−NH_2又は一N(CH_3)_3を示す。m及びn
は2〜14の整数を示す。) 2、式 ▲数式、化学式、表等があります▼ 又は式 ▲数式、化学式、表等があります▼ を有するフラン化合物を有効成分とする油脂酸化防止剤
。 (式中、R_1は水素原子、炭素数1〜24の直鎖状又
は分岐鎖状のアルキル基、同アルケニル基、グリコリル
基、又はコレステリール基を示し、R_2は炭素数1〜
24の直鎖状又は分岐鎖状のアルキル基、同アルケニル
基、グリコリル基、コレステリール基又は基 ▲数式、化学式、表等があります▼ を示し、Aは水素原子、−P(=O)(OH)_2、−
P(=O)(OH)−O−(CH_2)_2−B又は基
▲数式、化学式、表等があります▼ を示し、X及びYは同一か異なって水素原子又はメチル
基を示し、Bは−NH_2又は−N(CH_3)_3を
示す。m及びnは2〜14の整数を示す。)[Claims] 1. A furan compound having the formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼. (In the formula, R_2 represents a linear or branched alkyl group having 1 to 24 carbon atoms, an alkenyl group, a glycolyl group, a cholesteryl group, or a group (numerical formula, chemical formula, table, etc.), and A' is -P(=O)(OH)_2, -P(=O
)(OH)-O-(CH_2)_2-B, X and Y are the same or different and represent a hydrogen atom or a methyl group, and B represents -NH_2 or -N(CH_3)_3. m and n
represents an integer from 2 to 14. ) 2. An oil and fat antioxidant containing a furan compound as an active ingredient having the formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ or the formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼. (In the formula, R_1 represents a hydrogen atom, a linear or branched alkyl group having 1 to 24 carbon atoms, an alkenyl group, a glycolyl group, or a cholesteryl group, and R_2 represents a hydrogen atom having 1 to 24 carbon atoms.
24 linear or branched alkyl groups, alkenyl groups, glycolyl groups, cholesteryl groups or groups ▲ Numerical formulas, chemical formulas, tables, etc. are available ▼ where A is a hydrogen atom, -P(=O)( OH)_2,-
P(=O)(OH)-O-(CH_2)_2-B or group ▲There are mathematical formulas, chemical formulas, tables, etc.▼, X and Y are the same or different and represent a hydrogen atom or a methyl group, and B is -NH_2 or -N(CH_3)_3. m and n represent integers of 2 to 14. )
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62-155311A JPH013192A (en) | 1987-06-24 | Furan compounds and oil and fat antioxidants containing them as active ingredients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62-155311A JPH013192A (en) | 1987-06-24 | Furan compounds and oil and fat antioxidants containing them as active ingredients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS643192A JPS643192A (en) | 1989-01-06 |
| JPH013192A true JPH013192A (en) | 1989-01-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100918891B1 (en) | Production and use of an antioxidant extract from Crypthecodinium sp. | |
| Sindelar et al. | The protective role of plasmalogens in iron-induced lipid peroxidation | |
| Hildebrand et al. | Phospholipids plus tocopherols increase soybean oil stability | |
| JP3005226B2 (en) | Method for producing antioxidant mixture | |
| US20200397734A1 (en) | Purified compositions of polyunsaturated fatty acids, their preparation method and their use | |
| EP0665236B1 (en) | Phosphatidylcholine and process for producing the same | |
| HK1206198A1 (en) | Oxidized lipid compounds and uses thereof | |
| JP2007259866A (en) | Production and use of phosphatide | |
| EP2619194A1 (en) | Fatty acid derivatives of catechins and methods of their use | |
| WO1994010125A1 (en) | Glycerin derivatives and uses thereof | |
| KR20210006394A (en) | Polyunsaturated fatty acid composition rich in DHA | |
| JPH0517918B2 (en) | ||
| JPS6241209B2 (en) | ||
| JPH013192A (en) | Furan compounds and oil and fat antioxidants containing them as active ingredients | |
| JP2905275B2 (en) | Antioxidant composition | |
| IE41597B1 (en) | Synthetic phospholipids a process for their manufacture and their use | |
| JP3531876B2 (en) | Method for obtaining phospholipid composition containing docosahexaenoic acid | |
| US5364564A (en) | Phosphatidyl chromanol derivative, the production method thereof, antioxidant and emulsifier | |
| US5523429A (en) | N-acylphosphatidylethanolamines as anti-oxidants | |
| JPS635036A (en) | Squalene-containing composition | |
| CA1202586A (en) | Method for the preparation of physiological effectors | |
| JP2515839B2 (en) | Phospholipid purification method | |
| JPH03291289A (en) | Phosphatidyl ascorbate, production thereof, emulsifying agent, peroxylipid inhibitor and cosmetic | |
| JPH11292773A (en) | Cod liver oil, purification and use | |
| JPH10237081A (en) | Chromanol derivative, method for producing the same, and antioxidant |